The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

NCT04664829 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Triple-Negative Breast Carcinoma

Interventions

DRUG: Bexarotene
DRUG: Capecitabine

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]